James Ralston MD, MPH, is an internal medicine physician and senior investigator in health services and health informatics. His research mission is improving the health and care of patients living with common ongoing illnesses. His current areas of emphasis include understanding and honoring the priorities of patients living with multiple chronic conditions.
Dr. Ralston’s research focuses on developing and evaluating communication technologies that foster continuous care and a closer connection between patients and primary care teams. His commitment to finding effective ways to redesign care spans all stages of research, from project development to complete translation of results into clinical practice.
Examples of Dr. Ralston’s research projects include:
Dr. Ralston is also a University of Washington affiliate professor in health services and biomedical informatics, where he serves on the committees of PhD and master’s degree students.
Wiesner GL, Kulchak Rahm A, Appelbaum P, Aufox S, Bland ST, Blout CL, Christensen KD, Chung WK, Clayton EW, Green RC, Harr MH, Henrikson N, Hoell C, Holm IA, Jarvik GP, Kullo IJ, Lammers PE, Larson EB, Lindor NM, Marasa M, F Myers M, Peterson JF, Prows CA, Ralston JD, Milo Rasouly H, Sharp RR, Smith ME, Van Driest SL, Williams JL, Williams MS, Wynn J, Leppig KA. Returning results in the genomic era: initial experiences of the eMERGE Network. J Pers Med. 2020;10(2). pii: jpm10020030. doi: 10.3390/jpm10020030. PubMed
Schuttner L, Coleman K, Ralston J, Parchman M. The role of organizational learning and resilience for change in building quality improvement capacity in primary care. Health Care Manage Rev. 2021;46(2):E1-E7. doi: 10.1097/HMR.0000000000000281. PubMed
Gordon AS, Rosenthal EA, Carrell DS, Amendola LM, Dorschner MO, Scrol A, Stanaway IB, DeVange S, Ralston JD, Zouk H, Rehm HL, Larson E, Crosslin DR, Leppig KA, Jarvik GP. Rates of actionable genetic findings in individuals with colorectal cancer or polyps ascertained from a community medical setting. Am J Hum Genet. 2019 Sep 5;105(3):526-533. doi: 10.1016/j.ajhg.2019.07.012. Epub 2019 Aug 15. PubMed
Hartzler AL, Ralston JD, Hannan TA, Kelleher KJ, Penfold RB. Designing safer use of antipsychotics among youths: a human-centered approach to an algorithm-based solution. Psychiatr Serv. 2019 Jul 16:appips201800390. doi: 10.1176/appi.ps.201800390. [Epub ahead of print]. PubMed
Tchesnokova VL, Rechkina E, Chan D, Haile HG, Larson L, Ferrier K, Schroeder DW, Solyanik T, Shibuya S, Hansen K, Ralston JD, Riddell K, Scholes D, Sokurenko EV. Pandemic uropathogenic fluoroquinolone-resistant Escherichia coli have enhanced ability to persist in the gut and cause bacteriuria in healthy women. Clin Infect Dis. 2019 Jul 4. pii: ciz547. doi: 10.1093/cid/ciz547. [Epub ahead of print]. PubMed
Henrikson NB, Blasi PR, Corsmo JJ, Sheffer Serdoz E, Scrol A, Greene SM, Matthews TL, Ralston JD. "You really do have to know the local context": IRB administrators and researchers on the implications of the NIH Single IRB mandate for multisite genomic studies. J Empir Res Hum Res Ethics. 2019 Jul;14(3):286-295. doi: 10.1177/1556264619850440. Epub 2019 May 22. PubMed
Vizer LM, Eschler J, Koo BM, Ralston J, Pratt W, Munson S. "It's not just technology, it's people": constructing a conceptual model of shared health informatics for tracking in chronic illness management. J Med Internet Res. 2019 Apr 29;21(4):e10830. doi: 10.2196/10830. PubMed
Karter AJ, Warton EM, Moffet HH, Ralston JD, Huang ES, Miller DR, Lipska KJ. Revalidation of the hypoglycemia risk stratification tool using ICD-10 codes. Diabetes Care. 2019 Feb 14. pii: dc18-2154. doi: 10.2337/dc18-2154. [Epub ahead of print]. PubMed
O'Leary K, Tanghe D, Pratt W, Ralston J. Collaborative health reminders and notifications: insights from prototypes. AMIA Annu Symp Proc. 2018 Dec 5;2018:837-846. eCollection 2018. PubMed
Tchesnokova VL, Rechkina E, Larson L, Ferrier K, Weaver JL, Schroeder DW, She R, Butler-Wu SM, Aguero-Rosenfeld ME, Zerr D, Fang FC, Ralston J, Riddell K, Scholes D, Weissman S, Parker K, Spellberg B, Johnson JR, Sokurenko EV. Rapid and extensive expansion in the U.S. of a new multidrug-resistant Escherichia coli clonal group, sequence type ST1193. Clin Infect Dis. 2019 Jan 7;68(2):334-337. doi: 10.1093/cid/ciy525. PubMed
A new federal rule requiring physicians to give patients access to their notes may be easier to follow than physicians expected.
KPWHRI researchers uncover obstacles faced by smaller practices when adding CVD risk calculators into primary care.
Amy Lee describes how the LHS Program is helping KP Washington track and improve treatment for opioid use disorder.
All Washington members are invited to be part of research that could improve health for millions.
The Valuing Important Things in Active Lives (VITAL) study is a three-year project funded by the Agency for Healthcare Research and quality.
Learn about the VITAL study.
Medscape, April 29, 2021